Premium
Korro Bio Inc (KRRO)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company’s lead product candidate is KRRO-121 for the treatment for hyp... Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company’s lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson’s disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -2.95 | -21.884272997 | 13.48 | 13.52 | 10.5 | 113699 | 11.75820308 | CS |
| 4 | -2.2 | -17.2820109976 | 12.73 | 13.99 | 9.12 | 142143 | 11.48302284 | CS |
| 12 | -3.26 | -23.6403190718 | 13.79 | 15.555 | 9.12 | 164810 | 12.30082279 | CS |
| 26 | 3.76 | 55.5391432792 | 6.77 | 15.555 | 6.75 | 201400 | 11.03727465 | CS |
| 52 | -1.36 | -11.4381833474 | 11.89 | 55.89 | 5.2044 | 265401 | 16.50070586 | CS |
| 156 | -2.47 | -19 | 13 | 98 | 5.2044 | 152772 | 24.43274399 | CS |
| 260 | -2.47 | -19 | 13 | 98 | 5.2044 | 152772 | 24.43274399 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
